Search results
Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer's...
The Herald Journal· 1 day agoCEO David J. Bearss, Ph.D., will be participating in a panel discussing the "Landscape of Drug Discovery and Impact of AI Discussion" on Wednesday, May 22, from 1:50 to 2:30
Startling Discovery: Young Diabetics Show Early Signs of Alzheimer’s Disease
SciTechDaily· 6 days agoA study from CU Anschutz indicates that diabetes beginning in youth may increase the risk of...
Circular RNA: Vaccines, therapeutics and biomarkers could be revolutionised
Pharmaceutical Technology via Yahoo Finance· 6 hours agoCircRNA is still in very early days of development, but it is expected to trialled in vaccines,...
Research team identifies four new genetic risk factors for multiple system atrophy
Medical Xpress· 7 days agoIn a study published in Neuron, researchers have identified four new genetic risk factors for...
Psychological therapy shows promise in improving quality of life for people living with motor neuron...
Medical Xpress· 5 days agoMND is a progressive, neurodegenerative disease with no cure. It affects motor neurons, which are...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 8 hours agoAspen Neuroscience, Inc., a California-based private biotechnology company developing personalized regenerative therapies, has received a CLIN2 grant award of $8 million from the California ...
Why do people with dementia 'come back’ before death?
Cosmos· 5 days agoAlthough the person is still alive, dementia slowly and irreversibly chips away at their memories...
Coya Therapeutics Reports First Quarter 2024 Financial Results
Guru Focus· 5 days agoThe Houston-based clinical-stage biotechnology company reported a net loss of $5.1 million, which did not align with analyst expectations of a $4.43 million loss. Coya Therapeutics is at the ...
Earnings call: Quanterix sees 13% revenue growth in Q1 2024, driven by lab services By Investing.com
Investing.com· 6 days agoQuanterix (NASDAQ:QTRX) Corporation (ticker: QTRX), a company specializing in the development of...
Lots of drug companies talk about putting patients first — but this one actually did
NPR· 6 hours ago"But they didn't have to," she adds, "and that's concerning." Amylyx was founded by Klee and Cohen...